- Arrhythmogenic Right Ventricular Cardiomyopathy
- Dilated Cardiomyopathy
- Hypertrophic Cardiomyopathy
- Idiopathic Dilated Cardiomyopathy
- Idiopathic Hypertrophic Cardiomyopathy
- Idiopathic Restrictive Cardiomyopathy
- Restrictive Cardiomyopathy
Proposed Natural Treatments for Cardiomyopathy
Coenzyme Q 10
Herbs and Supplements to Use Only with Caution
1 Langsjoen H, Langsjoen P, Langsjoen P, et al. Usefulness of coenzyme Q 10 in clinical cardiology: a long-term study. Mol Aspects Med . 1994;15(suppl):S165–S175.
2 Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q 10 . Proc Natl Acad Sci USA . 1985;82:4240–4244.
3 Poggesi L, Galanti G, Comeglio M, et al. Effect of coenzyme Q 10 on left ventricular function in patients with dilative cardiomyopathy. Curr Ther Res . 1991;49:878–886.
4 Langsjoen PH, Langsjoen PH, Folkers K. A six-year clinical study of therapy of cardiomyopathy with coenzyme Q 10 . Int J Tissue React . 1990;12:169–171.
5 Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q 10 . Proc Natl Acad Sci USA . 1985;82:4240–4244.
6 Permanetter B, Rossy W, Klein G, et al. Ubiquinone (coenzyme Q 10 ) in the long-term treatment of idiopathic dilated cardiomyopathy. Eur Heart J . 1992;13:1528–1533.
7 Spigset O. Reduced effect of warfarin caused by ubidecarenone [letter]. Lancet. 1994;344:1372–1373.
8 Winter S, Jue K, Prochazka J, et al. The role of L-carnitine in pediatric cardiomyopathy. J Child Neurol . 1995;10(suppl 2):S45–S51.
9 Pepine CJ. The therapeutic potential of carnitine in cardiovascular disorders. Clin Ther . 1991;13:2–21.
10 Bertelli A, Ronca G. Carnitine and coenzyme Q 10 : biochemical properties and functions, synergism and complementary action. Int J Tissue React . 1990;12:183–186.
- Reviewer: EBSCO CAM Review Board
- Review Date: 08/2013 -
- Update Date: 08/22/2013 -